SYMPOSIUM ON SORBENTS IN UREMIA. 3. CHARCOAL HEMOPERFUSION IN TREATMENT OF DRUG OVERDOSAGE.GELFAND MC.1977; DIALYS. AND TRANSPLANT.; U.S.A.; DA. 1977; VOL. 6; NO 8; PP. 8-15 (5P.); BIBL. 22 REF.Article

HEMOPERFUSION RESULTS IN UREMIAGELFAND MC; WINCHESTER JF.1979; CLIN. NEPHROL.; DEU; DA. 1979; VOL. 11; NO 2; PP. 107-110; BIBL. 12 REF.Article

MECHANISM OF ALLOGRAFT REJECTION IN NEW ZEALAND MICE. I. CELL SYNERGY AND ITS AGE-DEPENDENT LOSS = MECANISME DU REJET D'ALLOGREFFE CHEZ LA SOURIS NEW ZEALAND. I. SYNERGIE CELLULAIRE ET SA PERTE SELON L'AGEGELFAND MC; STEINBERG AD.1973; J. IMMUNOL.; U.S.A.; DA. 1973; VOL. 110; NO 6; PP. 1652-1662; BIBL. 33REF.Serial Issue

PROLIFERATION OF MOUSE BONE MARROW-DERIVED LYMPHOCYTES IN VITRO. ONE MECHANISM OF RESPONSE TO CONCANAVALIN A AND PHYTOHEMAGGLUTININELFENBEIN GJ; GELFAND MC.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 17; NO 2; PP. 463-476; BIBL. 24 REF.Article

PLEURAL EFFUSION IN PATIENTS ON MAINTENANCE HEMODIALYSISTYLER JL; GELFAND MC.1978; DIALYS. AND TRANSPLANT.; USA; DA. 1978; VOL. 7; NO 12; PP. 1214-1230; (4 P.); BIBL. 14 REF.Article

PROLONGATION OF ALLOGRAFT SURVIVAL IN MICE BY ADMINISTRATION OF ANTI-THY 1 SERUM. I. MEDIATION BY IN VIVO ACTIVATION OF REGULATORY T CELLS.GELFAND MC; PAUL WE.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 1; PP. 1-4; BIBL. 13 REF.Article

ONTOGENY OF B LYMPHOCYTES. I. IN VITRO APPEARANCE OF IG-BEARING LYMPHOCYTESGELFAND MC; ASOFSKY R; PAUL WE et al.1974; CELL. IMMUNOL.; U.S.A.; DA. 1974; VOL. 14; NO 3; PP. 460-469; BIBL. 12REF.Article

MECHANISM OF ALLOGRAFT REJECTION IN NEW ZEALAND MICE. II. ROLE OF A SERUM FACTORGELFAND MC; PARKER LM; STEINBERG AD et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 113; NO 1; PP. 1-8; BIBL. 30REF.Article

GEOPHAGIA, A CAUSE OF LIFE-THREATENING HYPERKALEMIA IN PATIENTS WITH CHRONIC RENAL FAILURE = GEOPHAGIE. UNE CAUSE D'HYPERKALIEMIE MENACANT LA VIE CHEZ DES MALADES INSUFFISANTS RENAUX CHRONIQUESGELFAND MC; ZARATE A; KNEPSHIELD JH et al.1975; J. AMER. MED. ASS.; U.S.A.; DA. 1975; VOL. 234; NO 7; PP. 738-740; BIBL. 15 REF.Article

HEMOPERFUSION OF POISONS AND DRUGS IN CHILDRENJOSE PA; WINCHESTER JF; GELFAND MC et al.1981; CONTRIB. NEPHROL.; ISSN 0302-5144; CHE; DA. 1981; VOL. 27; PP. 61-64; BIBL. 11 REF.Article

BINDING SITES FOR IMMUNE COMPONENTS IN HUMAN CHOROID PLEXUSPERESS NS; ROXBURGH VA; GELFAND MC et al.1981; ARTHRITIS RHEUM.; ISSN 0004-3591; USA; DA. 1981 PUBL. 1980; VOL. 24; NO 3; PP. 520-526; BIBL. 29 REF.Article

A RECEPTOR FOR THE THIRD COMPONENT OF COMPLEMENT IN THE HUMAN RENAL GLOMERULUS.GELFAND MC; FRANK MM; GREEN I et al.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 4; PP. 1029-1034; BIBL. 10 REF.Article

KYRLE'S DISEASE IN PATIENTS WITH CHRONIC RENAL FAILUREHOOD AF; HARDEGEN GL; ZARATE AR et al.1982; ARCH. DERMATOL. (CHIC., 1960); ISSN 0003-987X; USA; DA. 1982; VOL. 118; NO 2; PP. 85-88; BIBL. 13 REF.Article

BINDING OF IGG-SENSITIZED ERYTHROCYTES BY MITRAL AND AORTIC CARDIAC VALVES: A POSSIBLE CLUE TO THE PATHOGENESIS OF IMMUNE VALVULAR HEART DISEASEGELFAND MC; MACLAY M; SHIN ML et al.1981; CLIN. IMMUNOL. IMMUNOPATHOL.; ISSN 0090-1229; USA; DA. 1981; VOL. 19; NO 2; PP. 151-160; BIBL. 12 REF.Article

SUPPRESSOR CELL ACTIVATION BY ANTI-THY 1.2 IN NZB/WF₁ MICE.KLASSEN LW; ZARATE A; GELFAND MC et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 6; PP. 2067-2072; BIBL. 27 REF.Article

THE GLOMERULAR COMPLEMENT RECEPTOR IN IMMUNOLOGICALLY MEDIATED RENAL GLOMERULAR INJURYGELFAND MC; SHIN ML; NAGLE RB et al.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 295; NO 1; PP. 10-14; BIBL. 18 REF.Article

THERAPEUTIC STUDIE IN NZB/W MICE. IV. EFFECET OF COMBINATION DRUG THERAPY ON IMMUNE COMPLEX DEPOSITIONGELFAND MC; SCHUR PH; ASOFSKY R et al.1976; ARTHRIT. AND RHEUMATISM; U.S.A.; DA. 1976; VOL. 19; NO 1; PP. 43-48; BIBL. 16 REF.Article

DETECTION OF ANTIPLATELET ANTIBODY ACTIVITY IN PATIENTS WITH RENAL CORTICAL NECROSIS = DETECTION DE L'ACTIVITE ANTICORPS ANTIPLAQUETTE CHEZ LES MALADES AVEC NECROSE CORTICALE RENALEGELFAND MC; FRIEDMAN EA; KNEPSHIELD JH et al.1974; KIDNEY INTERNATION.; GERM.; DA. 1974; VOL. 6; NO 6; PP. 426-430; ABS. FR.; BIBL. 24REF.Article

URINARY MONONUCLEAR CELL POPULATIONS IN RENAL INFECTION AND ALLOGRAFT REJECTIONGELFAND MC; GILAD V; LEE J et al.1979; TRANSPLANT. PROC.; USA; DA. 1979; VOL. 11; NO 2; PP. 1224-1225; BIBL. 1 REF.Article

BINDING OF RED CELLS COATED WITH IGG TO THE RENAL INTERSTITIUMGREEN I; GELFAND MC; FRANK MM et al.1980; MAJOR PROBL. DERMATOL.; ISSN 0301-7842; GBR; DA. 1980; VOL. 10; PP. 95-101; BIBL. 12 REF.Article

BINDING SITES FOR IMMUNE COMPLEXES CONTAINING IGG IN THE RENAL INTERSTITIUMGELFAND MC; FRANK MM; GREEN I et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 13; NO 1; PP. 19-29; BIBL. 20 REF.Article

THERAPEUTIC STUDIES IN NZB/W MICE. III. RELATIONSHIP BETWEEN RENAL STATUS AND EFFICACY OF IMMUNOSUPPRESSIVE DRUG THERAPY = ETUDES THERAPEUTIQUES CHEZ LES SOURIS NZB/W. III. RELATION ENTRE L'ETAT RENAL ET L'EFFICACITE DU TRAITEMENT PAR LES IMMUNOSUPPRESSEURSSTEINBERG AD; GELFAND MC; HARDIN JA et al.1975; ARTHRIT. AND RHEUMATISM.; U.S.A.; DA. 1975; VOL. 18; NO 1; PP. 9-14; BIBL. 19REF.Article

IRON-OVERLOAD-ASSOCIATED MYOPATHY IN PATIENTS ON MAINTENANCE HAEMODIALYSIS: A HISTOCOMPATIBILITY-LINKED DISORDERBREGMAN H; GELFAND MC; WINCHESTER JF et al.1980; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1980; NO 8200; PP. 882-885; BIBL. 28 REF.Article

SUCCESSFUL MANAGEMENT OF HEPATIC COMA BY HEMOCARBOPERFUSION.COLON AR; GELFAND MC; KNEPSHIELD JH et al.1976; J. PEDIATR.; U.S.A.; DA. 1976; VOL. 90; NO 6; PP. 1015-1016; BIBL. 9 REF.Article

TREATMENT OF DIGITALIS INTOXICATION BY CHARCOAL HEMOPERFUSION (CHP).CARVALLO A; RAMIREZ B; HONIG H et al.1976; TRANS., AMER. SOC. ARTIF. INTERN. ORGANS; U.S.A.; DA. 1976; VOL. 22; PP. 718-722; BIBL. 8 REF.Article